NeuroOne Executives Buy Shares, Signaling Confidence in StereoCED Breakthroughs
NeuroOne insiders buy 110k shares, signaling confidence in StereoCED trials and potential revenue growth amid a volatile market.
2 minutes to read
NEUROONE MEDICAL TECHNOLOGIE
NeuroOne CFO Buys 35K Options, Signals Confidence Amid Stock Slide
NeuroOne CFO’s fresh option buy signals confidence amid price dips, hinting that the new StereoCED platform could drive a rebound for the medical‑device stock.
3 minutes to read